DK1123089T3 - Tyggetablet med maskeret smag og omgående frigørelse af det aktive stof og fremgangsmåde til dens fremstilling - Google Patents

Tyggetablet med maskeret smag og omgående frigørelse af det aktive stof og fremgangsmåde til dens fremstilling

Info

Publication number
DK1123089T3
DK1123089T3 DK99950805T DK99950805T DK1123089T3 DK 1123089 T3 DK1123089 T3 DK 1123089T3 DK 99950805 T DK99950805 T DK 99950805T DK 99950805 T DK99950805 T DK 99950805T DK 1123089 T3 DK1123089 T3 DK 1123089T3
Authority
DK
Denmark
Prior art keywords
preparation
active substance
immediate release
chewable tablet
masked taste
Prior art date
Application number
DK99950805T
Other languages
English (en)
Inventor
Philippe Barthelemy
Hassan Benameur
Geraldine Cruminian
Original Assignee
Gattefosse Ets Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gattefosse Ets Sa filed Critical Gattefosse Ets Sa
Application granted granted Critical
Publication of DK1123089T3 publication Critical patent/DK1123089T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
DK99950805T 1998-10-23 1999-10-21 Tyggetablet med maskeret smag og omgående frigørelse af det aktive stof og fremgangsmåde til dens fremstilling DK1123089T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9813466A FR2784895B1 (fr) 1998-10-23 1998-10-23 Comprime a croquer a gout masque et liberation immediate du principe actif et procede de fabrication
PCT/FR1999/002563 WO2000024385A1 (fr) 1998-10-23 1999-10-21 Comprime a croquer a gout masque et liberation immediate du principe actif et procede de fabrication

Publications (1)

Publication Number Publication Date
DK1123089T3 true DK1123089T3 (da) 2003-10-13

Family

ID=9532051

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99950805T DK1123089T3 (da) 1998-10-23 1999-10-21 Tyggetablet med maskeret smag og omgående frigørelse af det aktive stof og fremgangsmåde til dens fremstilling

Country Status (10)

Country Link
EP (1) EP1123089B1 (da)
JP (1) JP2002528409A (da)
KR (1) KR20010080239A (da)
AT (1) ATE249208T1 (da)
AU (1) AU6344899A (da)
DE (1) DE69911224T2 (da)
DK (1) DK1123089T3 (da)
ES (1) ES2205887T3 (da)
FR (1) FR2784895B1 (da)
WO (1) WO2000024385A1 (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1313589B1 (it) * 1999-08-03 2002-09-09 Formenti Farmaceutici Spa Composizioni a rilascio controllato di paracetamolo.
JP2002138034A (ja) * 2000-10-27 2002-05-14 Kyoto Pharmaceutical Industries Ltd 苦味マスキングチュアブル錠およびその製造方法
WO2003004001A1 (en) 2001-07-06 2003-01-16 Lifecycle Pharma A/S Controlled agglomeration
FR2831820B1 (fr) * 2001-11-05 2004-08-20 Ethypharm Sa Comprime orodispersible presentant une grande homogeneite et son procede de preparation
CA2579097A1 (en) * 2004-09-02 2006-03-09 Quest International Services B.V. Heat stable flavouring compositions
JP4565219B2 (ja) * 2008-12-26 2010-10-20 アサヒビール株式会社 ポリフェノール含有顆粒またはポリフェノール含有チュアブル錠剤およびその製造方法
EP2704696A1 (en) 2012-03-26 2014-03-12 Glatt AG Taste-masked ibuprofen granules
FR3027802B1 (fr) 2014-10-31 2018-03-02 Ethypharm Granules de principe actif a double masquage de gout, leur procede de preparation et comprimes orodispersibles les contenant

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8730011D0 (en) * 1987-12-23 1988-02-03 Smithkline Dauelsberg Pharmaceutical compositions
CA2019324C (en) * 1989-07-10 1996-08-20 Robert L. Jerzewski Fosinopril tablet formulations
GB9224855D0 (en) * 1992-11-27 1993-01-13 Smithkline Beecham Plc Pharmaceutical compositions
JPH0971523A (ja) * 1995-09-07 1997-03-18 Riyuukakusan:Kk 口腔内で崩壊性の速い錠剤
FR2753904B1 (fr) * 1996-10-01 1998-10-30 Gattefosse Ets Sa Composition pharmaceutique a liberation modifiee de principe actif, comportant une matrice, et procede de fabrication
EP0839526A3 (en) * 1996-10-31 1999-01-07 Takeda Chemical Industries, Ltd. Solid pharmaceutical preparation with fast buccal disintegration or dissolution
US5891476A (en) * 1997-12-22 1999-04-06 Reo; Joe P. Tastemasked pharmaceutical system

Also Published As

Publication number Publication date
EP1123089A1 (fr) 2001-08-16
FR2784895B1 (fr) 2004-12-17
DE69911224D1 (de) 2003-10-16
JP2002528409A (ja) 2002-09-03
FR2784895A1 (fr) 2000-04-28
ATE249208T1 (de) 2003-09-15
AU6344899A (en) 2000-05-15
EP1123089B1 (fr) 2003-09-10
ES2205887T3 (es) 2004-05-01
DE69911224T2 (de) 2004-07-15
KR20010080239A (ko) 2001-08-22
WO2000024385A1 (fr) 2000-05-04

Similar Documents

Publication Publication Date Title
MXPA03005155A (es) 1,2-difenilazetidinonas novedosas, procesos para su preparacion, farmacos que contienen compuestos y su uso para el tratamiento del metabolismo afectado de los lipidos.
DE69939165D1 (de) N,n-disubstituierte amide welche die bindung von integrinen an ihre rezeptoren hemmen
DOP2001000238A (es) Proceso para la fabricacion de acidos n-aril-antrani- licos y sus derivados (process for making-aryl- anthranilic acids and their)
HUP9900337A2 (hu) Omega-3-Politelítetlen savak orális adagolási formái gyulladásos bélbetegségek kezelésére
DK0843558T3 (da) Sammensætning til forstærket optagelse af polære lægemidler fra colon
AR018609A1 (es) Composicion farmaceutica solida estabilizada que contiene un derivado de acido 4-amino-3-sustituido-butanoico y proceso para su preparacion.
PL345215A1 (en) Novel form of irbesartan, methods for obtaining said form and pharmaceutical compositions containing same
FR2795962B1 (fr) Procede de fabrication de granules enrobes a gout masque et liberation immediate du principe actif
HN1999000072A (es) Preparaciones farmaceuticas estabilizadas de gaba pentina y proceso para prepararla.
ATE211907T1 (de) Osmotisches arzneimittelfreisetzungssystem
CA2273420A1 (fr) Comprime matriciel permettant la liberation prolongee de gliclazide apres administration par voie orale
DK1123089T3 (da) Tyggetablet med maskeret smag og omgående frigørelse af det aktive stof og fremgangsmåde til dens fremstilling
BG101893A (en) Nodulosporic acid derivatives
DK0985411T3 (da) Sterolestere i tabletterede faste doseringsformer
DK0810883T3 (da) Konjugat indeholdende DTPA og albumin til individuel dosering af lægemidler
DE69714856D1 (de) Pharmazeutische zusammensetzung enthaltend einen embryonalen extrakt und verfahren zu ihrer herstellung
ES2122572T3 (es) Polvos solidos de acifluorfeno altamente concentrados y procesos para elaborar polvos solidos de acifluorfeno en forma seca.
MXPA02005474A (es) Fenotiazina en forma de pepitas.
GEP20043286B (en) Dual Inhibitors of Cholesteryl Ester and Wax Ester Synthesis for Sebaceous Gland Disorders
EE200100277A (et) Meetod tahkes ravimvormis ravimite valmistamisekstaimeekstraktidest
PT1001942E (pt) Poli-hidroxibutilpirazinas sua preparacao e medicamentos que as contem
ES2121278T3 (es) Agentes herbicidas a base de 2,6-dicloro-3-fluor-benzonitrilo y nuevos productos intermedios.
NZ333443A (en) Method of treating a plant disease comprising applying oxi-fulvic acid an acitve ingredient
FR2780402B1 (fr) Nouveaux composes acides carboxyliques et hydroxamiques inhibiteurs de metalloproteases, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
ATE322896T1 (de) Verbesserte pharmazeutische zusammensetzung mit einem ppar-alpha-mittel und verfahren zu ihrer herstellung